Pharmaceutical Sterility Testing Market

1
Pharmaceutical Sterility Testing Market Size,
Share Trends Analysis Report and Segment
Forecast, 2025 Grand View Research, Inc
The global pharmaceutical sterility testing
market size was valued USD 733.7 Million in
2016. It is estimated to register a CAGR of 11.8
over the forecast period.
The global Pharmaceutical Sterility Testing
Market size is expected to reach USD 2.0 billion
by 2025, according to a new report by Grand View
Research, Inc. The market is anticipated to
expand at a healthy CAGR of 11.8 over the
forecast period. Increasing number of drug
launches coupled with the rising RD expenditure
across the globe is expected to be the key
market growth drivers. Technological
advancements in sterility testing methods led to
reduction of the procedural time and human
intervention, thereby increasing the efficiency
and accuracy of these tests. Latest advancements
are flexible to suit the safety requirements of
innovative products. The FDA also relaxed its
regulatory requirements to allow the use of
modern sterility tests for ensuring product
safety. Outsourcing of sterility testing is a
strategy adopted by many companies in order to
reduce cost. Moreover, several contract
laboratories are available, which provide quality
sterility testing at economic prices. Outsourcing
of sterility testing also reduces the need for
personnel training, equipment purchases, and
manufacturing facility changes. Regulatory
framework for sterile products in pharmacies is
increasingly becoming stringent owing to the
several adverse events, such as meningitis
outbreak (2012), associated with unsafe sterile
products compounded in pharmacies. Moreover, the
Drug Quality and Security Act provides the FDA
authority to monitor and regulate the
compounding of drugs, thereby, increasing
adoption of sterility testing procedures by the
compounding pharmacies.
2

• Developing countries are harmonizing the
  regulatory framework with ICH standards and are
  also undertaking initiatives to boost the
  domestic production by providing incentives and
  tax concessions. Thus, developing nations are
  considered to be the future area for expansion of
  operations and outsourcing of sterility testing
  by multinational companies.
• To request a sample copy or view summary of this
  report, click the link below
• https//www.grandviewresearch.com/industry-analysi
  s/pharmaceutical-sterility-testing-market
• Further key findings from the study suggest
• The outsourcing pharmaceutical sterility testing
  market is anticipated to register a CAGR of 12.0
  over the forecast period
• Among end-users, the others segment includes
  hospitals, biopharmaceuticals, clinics, and
  research labs and it is anticipated to witness
  the maximum CAGR over the forecast period
• Bacterial endotoxin testing segment led the
  global pharmaceutical sterility testing market
  with a market share of over 39.0 in 2016
• The North America region is anticipated to expand
  at CAGR of 11.7 during the estimated period
• Developing countries, especially India and China,
  are expected to witness a remarkable growth over
  the coming years
• Some of the key companies in this market are SGS
  SA Toxikon, Inc. Pace Analytical Services, LLC
  Boston Analytical Charles River Laboratories
  International, Inc. and Nelson Laboratories LLC.
• Grand View Research has segmented the global
  pharmaceutical sterility testing market on the
  basis of type, test type, end-use, sample and
  region

3

• Medical Devices Companies
• Pharmaceutical Companies
• Others
• Pharmaceutical Sterility Testing Sample Outlook
  (Revenue, USD Million, 2014 - 2025)
• Sterile Drugs
• Medical Devices
• Biologics Therapeutics
• Pharmaceutical Sterility Testing Regional Outlook
  (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.

4

• Table of Content of Pharmaceutical Sterility
  Testing Market
• Chapter 1 Research Methodology
• Information procurement
• Information or Data Analysis
• Market Formulation Validation
• Chapter 2 Executive Summary
• 2.1 Market Snapshot
• Chapter 3 Market Variables, Trends Scope
• Market segmentation scope
• Market Driver Analysis
• Supportive government investment in the
  healthcare industry
• Increasing RD activities
• Increasing number of drug launches
• Increasing focus on quality and sterility
• Market Restraint Analysis
• Third party performance
• Penetration growth prospect mapping
• Pharmaceutical Sterility Testing - SWOT Analysis,
  By Factor (political legal, economic and
  technological)

5

• Bioburden testing
• Bioburden testing market, 2014 - 2025 (USD
  Million)
• Bacterial Endotoxin testing
• Bacterial Endotoxin testing market, 2014 - 2025
  (USD Million)
• Chapter 6 End-use Estimates Trend Analysis
• Pharmaceutical sterility testing market End-use
  movement analysis
• Compounding Pharmacies
• Compounding market, 2014 - 2025 (USD Million)
• Medical Devices Companies
• Medical devices companies market, 2014 - 2025
  (USD Million)
• Pharmaceutical companies
• Pharmaceutical companies market, 2014 - 2025 (USD
  Million)
• Others
• Others market, 2014 - 2025 (USD Million)
• Chapter 7 Sample Estimates Trend Analysis
• Pharmaceutical sterility testing market Sample
  movement analysis
• Sterile drugs
• Sterile drugs market, 2014 - 2025 (USD Million)
• Medical devices

6

• Europe pharmaceutical sterility testing market,
  2014 - 2025 (USD Million)
• U.K.
• U.K. pharmaceutical sterility testing market,
  2014 - 2025 (USD Million)
• Germany
• Germany pharmaceutical sterility testing market,
  2014 - 2025 (USD Million)
• Asia Pacific
• Asia Pacific pharmaceutical sterility testing
  market, 2014 - 2025 (USD Million)
• Japan
• Japan pharmaceutical sterility testing market,
  2014 - 2025 (USD Million)
• China
• China pharmaceutical sterility testing market,
  2014 - 2025 (USD Million)
• Latin America
• Latin America pharmaceutical sterility testing
  market, 2014 - 2025 (USD Million)
• Brazil
• Brazil pharmaceutical sterility testing market,
  2014 - 2025 (USD Million)
• Mexico
• Mexico pharmaceutical sterility testing market,
  2014 - 2025 (USD Million)
• MEA
• MEA pharmaceutical sterility testing market, 2014
  - 2025 (USD Million)

7

• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Boston Analytical.
• Company overview
• Financial performance
• Product Benchmarking
• Strategic initiatives
• Gibraltar Laboratories.
• Company overview
• Financial performance
• Service benchmarking
• Sartorius AG.
• Company overview
• Financial Performance
• Service benchmarking
• Strategic initiatives
• Solvias AG.

8

• Pace Analytical Services LLC.
• Company overview
• Financial Performance
• Product benchmarking
• Strategic initiatives
• Charles River Laboratories International, Inc.
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Thermo Fisher Scientific, Inc.
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Nelson Laboratories, Inc.
• Company overview
• Financial performance
• Product benchmarking

9
About Us Grand View Research, Inc. is a U.S.
based market research and consulting company,
registered in the State of California and
headquartered in San Francisco. The company
provides syndicated research reports, customized
research reports, and consulting services. To
help clients make informed business decisions,
the company offers market intelligence studies
ensuring relevant and fact-based research across
a range of industries including technology,
chemicals, materials, healthcare and
energy. Contact Sherry James Corporate Sales
Specialist, USA Grand View Research, Inc Phone
1-415- 349-0058 Toll Free 1-888- 202-9519 Email
sales_at_grandviewresearch.com For More Information
https//www.grandviewresearch.com Blog
https//healthcareforecastreport.blogspot.com/